Krämer, I., Hensel, M., Rieger, M., Horstmann, K., Hiddemann, W., Dreyling, M., . . . Ho, A. D. (2015). Pentostatin, cyclophosphamide and rituximab is a safe and effective treatment in patients with Waldenström’s macroglobulinemia. Leukemia and lymphoma, 56(1), . https://doi.org/10.3109/10428194.2014.911869
Chicago-Zitierstil (17. Ausg.)Krämer, Isabelle, Manfred Hensel, Michael Rieger, Kristin Horstmann, Wolfgang Hiddemann, Martin Dreyling, Silvia Koniczek, Mathias Witzens-Harig, und Anthony Dick Ho. "Pentostatin, Cyclophosphamide and Rituximab Is a Safe and Effective Treatment in Patients with Waldenström’s Macroglobulinemia." Leukemia and Lymphoma 56, no. 1 (2015). https://doi.org/10.3109/10428194.2014.911869.
MLA-Zitierstil (9. Ausg.)Krämer, Isabelle, et al. "Pentostatin, Cyclophosphamide and Rituximab Is a Safe and Effective Treatment in Patients with Waldenström’s Macroglobulinemia." Leukemia and Lymphoma, vol. 56, no. 1, 2015, https://doi.org/10.3109/10428194.2014.911869.